Blueprint Medicines News

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Lee Philina

Aug 7 17:12 ET

Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 5 16:53 ET

Blueprint Medicines | 10-Q: Q2 2024 Earnings Report

Aug 1 16:52 ET

Blueprint Medicines | 8-K: Blueprint Medicines Reports Second Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance

Aug 1 07:31 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Carter Percy H.

Jul 8 19:13 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Rossi Christina

Jul 8 19:13 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Durso-Bumpus Debra

Jul 8 16:08 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Durso-Bumpus Debra

Jul 2 16:10 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Durso-Bumpus Debra

Jun 25 16:01 ET

Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 21 17:56 ET

Blueprint Medicines | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 21 16:41 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.

Jun 14 17:45 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director COATS LONNEL

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Beckman Daniella

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Tsai John

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Seely Lynn

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Lydon Nicholas

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Goldberg Mark Alan

Jun 14 17:35 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Borisy Alexis

Jun 14 17:35 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Dable Habib J

Jun 14 17:35 ET